BMRN - Biomarin Pharmaceutical Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - BMRN (1048477)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
82 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S82-0-1-0-11

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-03-16
BMRNDavis George EricEVP, GCS - Sale$91.96-2,23873,729-3%-$205,806-1-4
2017-03-16
BMRNSpiegelman Daniel KEVP, CFOS - Sale$91.96-1,98914,471-12%-$182,908-1-4
DM
2017-03-15
BMRNBienaime Jean JacquesCEOS - Sale+OE$91.69-10,000373,475-3%-$916,900-1-4
D
2017-03-13
BMRNBienaime Jean JacquesCEOS - Sale+OE$92.68-5,000389,165-1%-$463,400-2-6
DM
2017-03-09
BMRNBienaime Jean JacquesCEOS - Sale+OE$90.59-11,000389,165-3%-$996,530-2-2
2017-03-07
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$90.56-5,00046,510-10%-$452,800+1+1
2017-03-06
BMRNSpiegelman Daniel KEVP, CFOS - Sale$93.32-2,30320,761-10%-$214,916+1+1
2017-03-06
BMRNDavis George EricEVP, GCS - Sale$93.32-1,49878,962-2%-$139,793+1+1
DM
2017-02-28
BMRNSpiegelman Daniel KEVP, CFOS - Sale+OE$94.07-35,00025,347-58%-$3,292,500+1-3
D
2017-03-01
BMRNLawlis V BryanDirS - Sale+OE$95.00-7,50013,860-35%-$712,500+1-3
DM
2017-01-25
BMRNBienaime Jean JacquesCEOS - Sale+OE$84.22-10,000353,483-3%-$842,200-1+2+6
DM
2017-01-10
BMRNBienaime Jean JacquesCEOS - Sale+OE$90.58-8,000353,483-2%-$724,600+10+5
DM
2017-01-06
BMRNBienaime Jean JacquesCEOS - Sale+OE$88.49-8,000353,483-2%-$707,920-5-6+1
2017-01-09
BMRNSpiegelman Daniel KEVP, CFOS - Sale$90.00-5,00018,100-22%-$450,000-5-6+1
DM
2016-12-29
BMRNBienaime Jean JacquesCEOS - Sale+OE$83.59-8,000353,483-2%-$668,760+1+6+3
D
2016-11-25
BMRNFuchs Henry JPres, Worldwide R, DS - Sale+OE$87.40-15,000113,878-12%-$1,310,988-1-5-3
DM
2016-11-21
BMRNBienaime Jean JacquesCEOS - Sale+OE$86.62-139,487353,483-28%-$12,082,993+1-3-5
D
2016-11-18
BMRNDavis George EricEVP, GCS - Sale+OE$90.42-5,00070,798-7%-$452,100+3+10
D
2016-11-16
BMRNBienaime Jean JacquesCEOS - Sale+OE$90.97-41,670349,126-11%-$3,790,795-20-5
2016-11-09
BMRNSpiegelman Daniel KEVP, CFOS - Sale$90.61-20,00023,100-46%-$1,812,206+2-3-9
D
2016-11-09
BMRNLawlis V BryanDirS - Sale+OE$95.00-7,50013,860-35%-$712,500+2-3-9
DM
2016-11-07
BMRNBienaime Jean JacquesCEOS - Sale+OE$82.67-140,000349,126-29%-$11,574,241+2+1-10
DM
2016-10-27
BMRNBienaime Jean JacquesCEOS - Sale+OE$81.30-120,000349,126-26%-$9,756,438+3+2+8
D
2016-10-17
BMRNBienaime Jean JacquesCEOS - Sale+OE$84.39-41,666349,126-11%-$3,516,2270-4+6
DM
2016-10-13
BMRNBienaime Jean JacquesCEOS - Sale+OE$86.96-64,125349,126-16%-$5,576,3770-4+9
D
2016-09-30
BMRNBienaime Jean JacquesCEOS - Sale+OE$92.02-53,125404,342-12%-$4,888,780+1-1-12
D
2016-09-29
BMRNBienaime Jean JacquesCEOS - Sale+OE$93.65-53,125404,342-12%-$4,974,901+1-1-15
2016-09-27
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$95.61-18,46741,342-31%-$1,765,6480+3-12
DM
2016-09-15
BMRNBienaime Jean JacquesCEOS - Sale+OE$95.34-137,368404,342-25%-$13,096,9610-1-13-8
D
2016-08-26
BMRNFuchs Henry JEVP, Chief Medical OfficerS - Sale+OE$95.06-15,000113,878-12%-$1,425,924-1+1+1-1
D
2016-08-16
BMRNBienaime Jean JacquesCEOS - Sale+OE$91.49-41,666404,342-9%-$3,811,8680+7+2-2
2016-08-01
BMRNSpiegelman Daniel KEVP, CFOS - Sale$99.33-4,00042,944-9%-$397,320+2-4-5-11
2016-08-01
BMRNDavis George EricEVP, GCS - Sale$100.00-2,16771,158-3%-$216,700+2-4-5-11
2016-08-01
BMRNMueller BrianVP, Corporate ControllerS - Sale$100.00-28714,260-2%-$28,700+2-4-5-11
D
2016-07-27
BMRNLawlis V BryanDirS - Sale+OE$95.39-1,10013,860-7%-$104,927+1+3-3-13
D
2016-07-22
BMRNLawlis V BryanDirS - Sale+OE$95.01-6,40013,860-32%-$608,064+7+9+8-8
D
2016-07-18
BMRNBienaime Jean JacquesCEOS - Sale+OE$92.72-41,666404,342-9%-$3,863,2720-20-7
2016-07-07
BMRNDavis George EricEVP, GCS - Sale$90.00-2,16770,669-3%-$195,030-1+4+11
2016-06-20
BMRNLawlis V BryanDirS - Sale$82.77-55013,860-4%-$45,524+1-8+15+5
D
2016-06-16
BMRNBienaime Jean JacquesCEOS - Sale+OE$80.55-41,666404,342-9%-$3,356,196-3-8+8+2
2016-06-06
BMRNSpiegelman Daniel KEVP, CFOS - Sale$89.14-1,64946,944-3%-$146,992-1-4+5-2
D
2016-05-31
BMRNSpiegelman Daniel KEVP, CFOS - Sale+OE$89.88-20,84150,394-29%-$1,873,126-2-8-16-5
D
2016-05-26
BMRNFuchs Henry JEVP, Chief Medical OfficerS - Sale+OE$87.81-15,000115,914-11%-$1,317,100-30-11-1
2016-05-23
BMRNSpiegelman Daniel KEVP, CFOS - Sale$87.07-3,76958,644-6%-$328,184+1-1-5-1
2016-05-18
BMRNBaffi RobertEVP, Technical OperationsS - Sale$87.05-5,000162,062-3%-$435,249-3+2-4+6
M
2016-05-09
BMRNDavis George EricEVP, GCS - Sale$85.11-14,65875,540-16%-$1,247,611-6-1-4-6
D
2016-05-05
BMRNBienaime Jean JacquesCEOS - Sale+OE$80.15-50,000415,914-11%-$4,007,445+4-2+2-7
2016-05-03
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$86.03-41563,072-1%-$35,701-2+6+11-2
D
2016-05-02
BMRNBienaime Jean JacquesCEOS - Sale+OE$85.01-36,500421,393-8%-$3,102,931-3+3+8-5
2016-03-14
BMRNDavis George EricEVP, GCS - Sale$86.21-1,99676,190-3%-$172,079-40+6+13
2016-03-04
BMRNAjer Jeffrey RobertSVP, Chief Commercial OfficerS - Sale$88.42-1,25546,882-3%-$110,970-30-6+8
2016-03-01
BMRNBienaime Jean JacquesCEOS - Sale$84.28-10,000366,258-3%-$842,769+2-2-6+9
2016-03-02
BMRNSpiegelman Daniel KEVP, CFOS - Sale$86.12-4,62349,688-9%-$398,120+2-2-6+9
D
2016-02-22
BMRNGrey Michael GDirS - Sale+OE$80.00-7,50026,250-22%-$600,000+1+8+10+21
2015-12-16
BMRNDavis George EricSVP, GCS - Sale$100.00-1,36266,156-2%-$136,200-1+4-22-18
2015-11-30
BMRNBienaime Jean JacquesCEOS - Sale$94.74-1,000254,5120%-$94,744-20+9-4
D
2015-11-16
BMRNLawlis V BryanDirS - Sale+OE$106.90-8,55011,850-42%-$913,998-4-9-7-21
D
2015-11-16
BMRNGrey Michael GDirS - Sale+OE$104.27-7,50026,250-22%-$782,054-4-9-7-21
D
2015-11-16
BMRNSpiegelman Daniel KEVP, CFOS - Sale+OE$104.30-20,00028,229-41%-$2,085,918-4-9-7-21
2015-11-02
BMRNAjer Jeffrey RobertSVP, Chief Commercial OfS - Sale$117.56-2635,6050%-$3,057-3-7-17-28
2015-10-15
BMRNBienaime Jean JacquesCEOS - Sale$108.24-1,000255,5120%-$108,241-1-4-4-21
2015-09-14
BMRNBienaime Jean JacquesCEOS - Sale$131.43-1,000256,5120%-$131,432+2-8-19-37
2015-08-12
BMRNBienaime Jean JacquesCEOS - Sale$134.72-1,500257,512-1%-$202,083-1-1-3-51
D
2015-07-20
BMRNAjer Jeffrey RobertSVP, Chief Commercial OfS - Sale+OE$150.00-3,00035,605-8%-$450,0000+1-6-43
2015-07-07
BMRNBienaime Jean JacquesCEOS - Sale$139.07-1,500259,012-1%-$208,600+1+4-4-29
2015-06-05
BMRNSpiegelman Daniel KEVP, CFOS - Sale$122.30-1,64928,229-6%-$201,669-3-2+13-24
2015-06-05
BMRNFuchs Henry JEVP, Chief Medical OfficerS - Sale$122.32-1,86472,846-2%-$228,001-3-2+13-24
2015-06-04
BMRNAjer Jeffrey RobertSVP, Chief Commercial OfS - Sale$122.35-1,36235,605-4%-$166,646-3-2+13-24
M
2015-05-29
BMRNSpiegelman Daniel KEVP, CFOS - Sale$124.73-5,52331,679-15%-$688,876-3-3+10-23
2015-06-01
BMRNAjer Jeffrey RobertSVP, Chief Commercial OfS - Sale$123.76-37738,455-1%-$46,657-3-3+10-23
2015-05-18
BMRNSpiegelman Daniel KEVP, CFOS - Sale$130.00-34,07841,507-45%-$4,430,140-1-3+6-23
2015-05-21
BMRNBienaime Jean JacquesCEOS - Sale$126.11-1,500267,652-1%-$189,157+2-2+9-19
2015-05-26
BMRNAjer Jeffrey RobertSVP, Chief Commercial OfS - Sale$126.55-1,62539,245-4%-$205,647+2-2+9-19
2015-05-18
BMRNSpiegelman Daniel KEVP, CFOS - Sale$124.77-2,05975,585-3%-$256,905+2+2-1-14
2015-05-18
BMRNFuchs Henry JEVP, Chief Medical OfficerS - Sale$124.78-1,86476,746-2%-$232,584+2+2-1-14
2015-05-18
BMRNDavis George EricSVP, GCS - Sale$125.26-2,55869,226-4%-$320,415+2+2-1-14
2015-05-13
BMRNFuchs Henry JEVP, Chief Medical OfficerS - Sale$121.36-1,43480,646-2%-$174,0380+4-1-9
2015-05-11
BMRNFuchs Henry JEVP, Chief Medical OfficerS - Sale$121.64-2,86983,646-3%-$348,9880+4+1-5
D
2015-05-06
BMRNAjer Jeffrey RobertSVP, Chief Commercial OfS - Sale+OE$119.14-34,01942,645-44%-$4,053,042-1+1+2-7
D
2015-05-01
BMRNBienaime Jean JacquesCEOS - Sale+OE$114.98-26,723281,912-9%-$3,072,509+5+6+8+3
2015-05-01
BMRNFuchs Henry JEVP, Chief Medical OfficerS - Sale$114.59-41489,6460%-$47,442+5+6+8+3
D
2015-04-01
BMRNBienaime Jean JacquesCEOS - Sale+OE$120.53-26,052284,509-8%-$3,140,136-1+2-3-9

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top